News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Resverlogix Announces New Research Highlighting Apabetalone’s Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19
March 2, 2023
·
6 min read
Business
BioMark Provides Third Quarter Operational Update and 2023 Outlook
March 1, 2023
·
7 min read
Business
Britannia Life Sciences Inc. Announces Third Quarter Results
March 1, 2023
·
3 min read
Business
Therma Bright, Announces Appointment of Dr. John Patton as Chairman to Investee Company InStatin Inc.
March 1, 2023
·
4 min read
Business
Well Told Announces Details of Election to Issue Common Shares in Satisfaction of Convertible Debenture Interest Payment Obligations
March 1, 2023
·
7 min read
Moss Announces Grant of Incentive Stock Options
February 28, 2023
·
2 min read
Braxia Scientific Announces Closing of First Tranche of LIFE Offering and Concurrent Private Placement
February 28, 2023
·
7 min read
With a Two-Year Revenue Growth of 276%, PathogenDx Ranks No. 50 on Inc. Magazine’s List of the Southwest Region’s Fastest-Growing Private Companies
February 28, 2023
·
5 min read
Awakn Life Sciences Signs Its Fourth Licensing Partnership Agreement in North America, and First in California
February 28, 2023
·
6 min read
Genetown
CureDuchenne Ventures Invests in hC Bioscience And its Novel tRNA-Based Therapeutic Approach for Duchenne Muscular Dystrophy
February 28, 2023
·
2 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us